SYNCROSOME CIR accreditation


For more than 6 years now, Syncrosome has worked as a preclinical CRO accredited by the French Ministry of Higher Education and Research for Research Tax Credits (CIR).

Our recognition procures a significant financial benefit for French companies wishing to pursue their R & D work in Cardiovascular, Central Nervous System, Respiratory or Gastrointestinal field with Syncrosome.
This authorization is accorded for the years 2015 to 2019.

A few words about Syncrosome:

Syncrosome is an Efficacy Characterization CRO and we offer relevant disease models, cutting-edge techniques and a comprehensive background of physiopathology to assist drug discovery companies.

We have developped and validated so far more than 15 disease models, and our flexible and human-sized organization can design and operate tailored experimental protocols to give you appropriate answers.

Our main activities consit in :

  • Drug Efficacy Studies in several therapeutic areas :
    • Central Nervous Sytem,
    • Cardiovascular and Metabolic disease,
    • Respiratory,
    • Gastrointestinal.
  • Early bioavailibility and CNS-PK on rodents and non-rodents with a high competence in the study of the Blood Brain Barrier passage.